John Tierney has an article in the New York Times questioning whether science is really being restored "to its rightful place" by the new US administration. He cites statements from Steven Chu and John Holdren that seem somewhat sensational in tone, and says, "Will Mr. Obama's scientific counselors give him realistic plans for dealing with global warming and other threats? To borrow a term from Roger Pielke Jr.: Can these scientists be honest brokers?"

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.